menu
    • menu

    Company profile for XBiotech

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Unlike previous generations of antibody therapies, XBiotech’s True Human™ antibodies are 100 percent human, derived from individuals who possess natural immunity to certain diseases. With the discovery and clinical pro...
    XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Unlike previous generations of antibody therapies, XBiotech’s True Human™ antibodies are 100 percent human, derived from individuals who possess natural immunity to certain diseases. With the discovery and clinical programs across multiple disease areas, XBiotech’s True Human™ antibodies have the potential to harness the body’s natural immunity to fight disease with increased safety, efficacy and tolerability.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XBiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5217 WINNEBAGO LN. AUSTIN, TX 78744
    Telephone
    Telephone
    +1 5123862900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.xbiotech.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/xbiotech-usa-inc.
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XBiotech Pauses Rheumatology program
    XBiotech Pauses Rheumatology program

    23 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/23/3001269/35550/en/XBiotech-Pauses-Rheumatology-program.html

    GLOBENEWSWIRE
    23 Dec 2024
    Share Share
    XBiotech Study Suggests Breakthrough For Advanced Pancreatic Cancer
    XBiotech Study Suggests Breakthrough For Advanced Pancreatic Cancer

    18 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/18/2900654/35550/en/XBiotech-Results-from-Randomized-Double-Blinded-Phase-1-2-Study-Suggest-Potential-Breakthrough-Treatment-for-Advanced-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    18 Jun 2024
    Share Share
    XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
    XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

    04 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/04/2804040/35550/en/XBiotech-to-Begin-Constructing-New-R-D-Facility-on-its-48-acre-Campus.html

    GLOBENEWSWIRE
    04 Jan 2024
    Share Share
    Dr. Alan Kivitz to Chair XBiotech™s Natrunix Program in Rheumatoid Arthritis
    Dr. Alan Kivitz to Chair XBiotech™s Natrunix Program in Rheumatoid Arthritis

    14 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/14/2780180/35550/en/Dr-Alan-Kivitz-to-Chair-XBiotech-s-Natrunix-Program-in-Rheumatoid-Arthritis.html

    GLOBENEWSWIRE
    14 Nov 2023
    Share Share
    XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin
    XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin

    26 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/26/2749600/35550/en/XBiotech-Announces-Enrollment-Completion-of-Phase-I-Clinical-Trial-for-Hutrukin-a-Novel-Candidate-Therapy-for-Stroke.html

    GLOBENEWSWIRE
    26 Sep 2023
    Share Share
    XBiotech Announces Enrollment Completion of Ph II, Placebo Controlled
    XBiotech Announces Enrollment Completion of Ph II, Placebo Controlled

    30 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/30/2734388/35550/en/XBiotech-Announces-Enrollment-Completion-of-Phase-II-Placebo-Controlled-Multicenter-Study-for-Natrunix-in-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    30 Aug 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search